SFRP4 is a diabesity biomarker induced by an increase in IL-1β levels, and this inflammatory mediator hinders the exocytosis of insulin-secreting granules from the pancreatic β-cells, leading to T2DM development [96]. The gene discussed is INS; the disease is type 2 diabetes mellitus.